S. Battella

发表

Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs

C. Capuano, C. Pighi, S. Battella, 2021, Cancers.

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production

G. Giannini, A. Santoni, C. Capuano, 2017, Oncoimmunology.

CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis

C. Klein, A. Santoni, S. Morrone, 2020, Cancer Immunology, Immunotherapy.

Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming

O. Turriziani, A. Santoni, S. Morrone, 2018, Front. Immunol..

Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD)

A. Santoni, S. Oliva, S. Morrone, 2019, Mucosal Immunology.

T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells.

D. Lauro, C. Palumbo, Maria Michela D’Aloia, 2016, Cytotherapy.

Size and dynamics of mucosal and peripheral IL-17A+ T-cell pools in pediatric age, and their disturbance in celiac disease

A. Santoni, R. Nenna, L. Petrarca, 2012, Mucosal Immunology.

Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab

C. Albertoni, A. Anastasi, L. Aurisicchio, 2014, Oncotarget.

Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature

A. Folgori, A. Nicosia, A. Hayday, 2022, bioRxiv.

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results

A. Folgori, A. Bacchieri, C. Agrati, 2022, npj Vaccines.

Effect of Surgery on Pancreatic Tumor-Dependent Lymphocyte Asset

G. Peruzzi, F. Iannone, S. Morrone, 2015, Pancreas.

GRAd-COV2, a gorilla adenovirus based candidate vaccine against COVID-19, is safe and immunogenic in young and older adults

A. Folgori, G. Kroemer, C. Agrati, 2021, medRxiv.

Regulation and trafficking of the HLA‐E molecules during monocyte‐macrophage differentiation

A. Santoni, Antonino Cassotta, M. Fiorillo, 2016, Journal of leukocyte biology.

GRAd-COV2 vaccine provides potent and durable immunity in a randomised placebo-controlled phase 2 trial (COVITAR)

A. Folgori, S. Leone, G. Missale, 2022, medRxiv.

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

A. Folgori, G. Kroemer, C. Agrati, 2021, Science Translational Medicine.

Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy

A. Santoni, L. Ruco, A. Di Napoli, 2017, Cancer Immunology, Immunotherapy.

Natural killer (NK) cells and anti‐tumor therapeutic mAb: unexplored interactions

A. Santoni, S. Battella, G. Palmieri, 2016, Journal of leukocyte biology.

Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients

A. Santoni, L. Ruco, A. Di Napoli, 2015, Oncoimmunology.

Memory NK Cell Features Exploitable in Anticancer Immunotherapy

A. Santoni, C. Capuano, C. Pighi, 2019, Journal of immunology research.

(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition

O. Turriziani, G. Sciumè, C. Santoro, 2022, Biomedicines.

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19

A. Folgori, J. Ball, C. Castilletti, 2020, bioRxiv.

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

A. Folgori, S. Leone, G. Missale, 2023, Cell Reports Medicine.

A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition

W. Weissenhorn, R. Weiss, J. Simorre, 2013, PLoS pathogens.